Sayah David M, Mallavia Beñat, Liu Fengchun, Ortiz-Muñoz Guadalupe, Caudrillier Axelle, DerHovanessian Ariss, Ross David J, Lynch Joseph P, Saggar Rajan, Ardehali Abbas, Ware Lorraine B, Christie Jason D, Belperio John A, Looney Mark R
1 Division of Pulmonary and Critical Care Medicine, Department of Medicine, and.
Am J Respir Crit Care Med. 2015 Feb 15;191(4):455-63. doi: 10.1164/rccm.201406-1086OC.
Primary graft dysfunction (PGD) causes early mortality after lung transplantation and may contribute to late graft failure. No effective treatments exist. The pathogenesis of PGD is unclear, although both neutrophils and activated platelets have been implicated. We hypothesized that neutrophil extracellular traps (NETs) contribute to lung injury in PGD in a platelet-dependent manner.
To study NETs in experimental models of PGD and in lung transplant patients.
Two experimental murine PGD models were studied: hilar clamp and orthotopic lung transplantation after prolonged cold ischemia (OLT-PCI). NETs were assessed by immunofluorescence microscopy and ELISA. Platelet activation was inhibited with aspirin, and NETs were disrupted with DNaseI. NETs were also measured in bronchoalveolar lavage fluid and plasma from lung transplant patients with and without PGD.
NETs were increased after either hilar clamp or OLT-PCI compared with surgical control subjects. Activation and intrapulmonary accumulation of platelets were increased in OLT-PCI, and platelet inhibition reduced NETs and lung injury, and improved oxygenation. Disruption of NETs by intrabronchial administration of DNaseI also reduced lung injury and improved oxygenation. In bronchoalveolar lavage fluid from human lung transplant recipients, NETs were more abundant in patients with PGD.
NETs accumulate in the lung in both experimental and clinical PGD. In experimental PGD, NET formation is platelet-dependent, and disruption of NETs with DNaseI reduces lung injury. These data are the first description of a pathogenic role for NETs in solid organ transplantation and suggest that NETs are a promising therapeutic target in PGD.
原发性移植肺功能障碍(PGD)可导致肺移植术后早期死亡,并可能导致晚期移植肺失功。目前尚无有效治疗方法。尽管中性粒细胞和活化血小板都与之有关,但PGD的发病机制尚不清楚。我们推测中性粒细胞胞外陷阱(NETs)以血小板依赖的方式导致PGD中的肺损伤。
研究PGD实验模型和肺移植患者中的NETs。
研究了两种实验性小鼠PGD模型:肺门钳夹和长时间冷缺血后的原位肺移植(OLT-PCI)。通过免疫荧光显微镜和酶联免疫吸附测定法评估NETs。用阿司匹林抑制血小板活化,并用脱氧核糖核酸酶I破坏NETs。还对有或无PGD的肺移植患者的支气管肺泡灌洗液和血浆中的NETs进行了检测。
与手术对照组相比,肺门钳夹或OLT-PCI后NETs增加。OLT-PCI中血小板的活化和肺内聚集增加,抑制血小板可减少NETs和肺损伤,并改善氧合。经支气管给予脱氧核糖核酸酶I破坏NETs也可减轻肺损伤并改善氧合。在人类肺移植受者的支气管肺泡灌洗液中,PGD患者的NETs更为丰富。
在实验性和临床PGD中,NETs均在肺中积聚。在实验性PGD中,NET的形成是血小板依赖的,用脱氧核糖核酸酶I破坏NETs可减轻肺损伤。这些数据首次描述了NETs在实体器官移植中的致病作用,并表明NETs是PGD中一个有前景的治疗靶点。